Genome-Driven Therapy for Chemotherapy-Resistant Metastatic <i>CDK6</i>-Amplified Osteosarcoma.

Genome-Driven Therapy for Chemotherapy-Resistant Metastatic CDK6-Amplified Osteosarcoma.

Lazow, Margot A; Johnson, Sheryl L; Johnson, Neil D; Breneman, John C; Dexheimer, Phillip J; Szabo, Sara; Pressey, Joseph G.

Afiliação

Lazow MA; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Johnson SL; Division of Pathology and Laboratory Medicine, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Johnson ND; Department of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH.
Breneman JC; Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Dexheimer PJ; Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, OH.
Szabo S; Department of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Pressey JG; Division of Pathology and Laboratory Medicine, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

JCO Precis Oncol ; 4: 498-504, 2020 Nov.

Article em En | MEDLINE | ID: mdl-35050742

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article